Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis

Summary

The transcription factor GATA-1, together with its cofactor FOG-1, regulates erythropoiesis and megakaryocytopoiesis. Mutations in the DNA or FOG-1 binding sites of its N-terminal zinc finger result in different illnesses. Alterations of the FOG-1 face are responsible for dyserythropoietic anemia with thrombocytopenia while R216Q, the only mutation identified in the DNA face, induces X-linked thrombocytopenia with thalassemia (XLTT). The former disorder has been studied in detail whereas little is known about the latter since only one family has been investigated. We studied a second family with an R216Q, showing that XLTT and dyserythropoietic anemia with thrombocytopenia, even if different clinical entities, are closely related disorders. In both cases, patients present mild dyserythropoiesis, red cell hemolysis, severely defective maturation of megakaryocytes, macrothrombocytopenia with α-granule deficiency, and abnormalities of the cytoplasmic membrane system. However, a thalassemia minor phenotype has only been described in patients with XLTT whereas severe anemia and thrombocytopenia with evident defects of platelet composition and function may be observed only in dyserythropoietic anemia with thrombocytopenia.

Keywords

GATA-1 - thrombocytopenia - thalassemia - platelets - megakaryocytes

• References

• 1 Orkin SH. GATA-binding transcription factors in hematopoietic cells. Blood 1992; 80: 575-81.
• 2 Weiss MJ, Orkin SH. GATA transcription factors: key regulators of hematopoiesis. Exp Hematol 1995; 23: 99-107.
• 3 Lowry JA, Atchley WR. Molecular evolution of the GATA family of transcription factors: conservation within the DNA-binding domain. J Mol Evol 2000; 50: 103-5.
• 4 Weiss MJ, Yu C, Orkin SH. Erythroid-cellspecific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol Cell Biol 1997; 17: 1642-51.
• 5 Tsang AP, Visvader JE, Turner CA. et al. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 1997; 90: 109-19.
• 6 Shivdasani RA. Molecular and transcriptional regulation of megakaryocyte differentiation. Stem Cells 2001; 19: 397-407.
• 7 Nichols KE, Crispino JD, Poncz M. et al. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1 . Nat Genet 2000; 24: 266-70.
• 8 Mehaffey MG, Newton AL, Gandhi MJ. et al. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2001; 98: 2681-8.
• 9 Freson K, Devriendt K, Matthijs G. et al. Platelet characteristics in patients with Xlinked macrothrombocytopenia because of a novel GATA1 mutation. Blood 2001; 98: 85-92.
• 10 Freson K, Matthijs G, Thys C. et al. Different substitutions at the residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet 2002; 11: 147-52.
• 11 Yu C, Niakan KK, Matsushita M. et al. Xlinked thrombocytopenia with thalassemia due to a mutation in the amino-finger of GATA-1 affecting DNA-binding rather than FOG-1 interaction. Blood 2002; 100: 2040-5.
• 12 Thompson AR, Wood WG, Stamatoyannopoulos G. X-linked syndrome of platelet dysfunction, thrombocytopenia, and imbalanced globin chain synthesis with hemolysis. Blood 1977; 50: 303-16.
• 13 Raskind WH, Niakan KK, Wolff J. et al. Mapping of a syndrome of X-linked thrombocytopenia with thalassemia to band Xp11-12: further evidence of genetic heterogeneity of X-linked thrombocytopenia. Blood 2000; 95: 2262-8.
• 14 Toomey KC, Kim HC, Kosmin M. et al. Clinical trial of a new disposable bleeding time device. Am J Clin Pathol 1986; 85: 610-6.
• 15 Savoia A, Balduini CL, Savino M. et al. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001; 97: 1330-5.
• 16 Weatherall DJ, Clegg JB, Boon WB. Globin synthesis in thalassemia: an in vitro study. Nature 1965; 208: 1061-5.
• 17 Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the detemination of β-like globin cluster haplotype. Am J Hematol 1989; 32: 66-9.
• 18 Rosatelli MC, Tuveri T, Scalas MT. et al. Molecular screening and fetal diagnosis of β-thalassemia in the Italian population. Hum Genet 1992; 89: 585-9.
• 19 Grosso M, Esposito G, Rescigno G. et al. Rapid identification of β− and δβ-thalassemia mutations by a variety of PCR based procedures. Br J Haematol 1994; 87 suppl. (Suppl. 01) 61.
• 20 Thein SL, Wood WG, Wickramasinghe SN. et al. β-Thalassemia unlinked to the β-globin gene in an English family. Blood 1993; 82: 961-7.
• 21 Beris PH, Solenthaler M, Deutsch S. et al. Severe inclusion body β-thalassemia with haemolysis in a patient double heterozygous for β°-thalassemia and quadruplicated α-globin gene arrangement of the anti-4.2 type. Br J Haematol 1999; 105: 1074-80.
• 22 Shimizu K, Harano K, Miwa S. et al. Abnormal arrangements in the α− and γ-globin gene cluster in a relatively large group of Japanese newborns. Am J Hum Genet 1986; 38: 45-58.
• 23 Goossens M, Kan YY. DNA analysis in the diagnosis of hemoglobin disorders. Methods Enzymol 1981; 76: 805-17.
• 24 Tonon L, Bergamaschi G, Dellavecchia C. et al. Unbalanced X-chromosome inactivation in hae-mopoietic cells from normal women. Br J Haematol 1998; 102: 996-1003.
• 25 Busque L, Zhu J, DeHart D. et al. An expression based clonality assay at the human androgen receptor locus (HUMARA) on chromosome X. Nucleic Acids Res 1994; 22: 697-8.
• 26 Chiavegato A, Capriani A, Azzarello G. et al. Expression of non-muscle myosin isoforms in rabbit myometrium is estrogen-dependent. Cell Tissue Res 1996; 283: 7-18.
• 27 Noris P, Spedini P, Belletti S. et al. Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly): clinical and laboratory findings. Am J Med 1998; 104: 355-60.
• 28 Hogge D, Fanning S, Bockhold K. et al. Quantitation and characterization of human megakaryocyte colony-forming cells using a standardized serum-free agarose assay. Br J Haematol 1997; 96: 790-800.
• 29 Orkin SH, Kazazian HH, Antonarakis SE. et al. Linkage of β-thalassemia mutations and β-globin gene polymorphisms with DNA polymorphisms in human β-globin gene cluster. Nature 1982; 296: 627-31 30.
• 30 Williams N, Levine RE. The origin, development and regulation of megakaryocytes. Br J Haematol 1982; 52: 173-80.
• 31 Hashimoto Y, Ware J. Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene. J Biol Chem 1995; 270: 24532-9.
• 32 Hickey MJ, Roth GJ. Characterization of the gene encoding human platelet glycoprotein IX. J Biol Chem 1993; 268: 3438-43.
• 33 Sato N, Kiyokawa N, Taguchi T. et al. Functional conservation of platelet glycoprotein V promoter between mouse and human megakaryocytes. Exp Hematol 2000; 28: 802-14.
• 34 White JG, de Alarcon PA. Platelet spherocytosis: a new bleeding disorder. Am J Hematol 2002; 70: 158-66.
• 35 Rocca B, Ranelletti FO, Maggiano N. et al. Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features. Thromb Haemost 2000; 83: 35-41.
• 36 White JG, Rao GHR. Microtubule coils versus the surface membrane cytoskeleton in maintenance and restoration of platelet discoid shape. Am J Pathol 1998; 165: 597-610.
• 37 Steiner M. Fluorescence studies of platelet tubulin. Biochemistry 1980; 19: 4492-9.
• 38 Ravid K, Doi T, Beeler DL. et al. Transcriptional regulation of the rat platelet factor 4 gene: interaction between an enhancer/silencer domain and the GATA site. Mol Cell Biol 1991; 11: 6116-27.
• 39 Rojnuckarin P, Kaushansky K. Actin reorganization and proplatelet formation in murine megakaryocytes: the role of protein kinase alpha. Blood 2001; 97: 154-61.
• 40 Horak CE, Mahajan MC, Luscombe NM. et al. GATA-1 binding sites mapped in the β-globin locus by using mammalian chIp-chip analysis. Proc Natl Acad Sci USA 2002; 99: 2924-9.
• 41 Rachmilewitz EA, Aker M. The role of recombinant human erythropoietin in the treatment of thalassemia. Ann N Y Acad Sci 1998; 850: 129-38.
• 42 Fujiwara Y, Browne CP, Cunniff K. et al. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc Natl Acad Sci USA 1996; 93: 12355-8.
• 43 McDevitt MA, Shivdasani RA, Fujiwara Y. et al. A “knockdown” mutation created by ciselement gene targeting reveals the dependence of erythroid cell maturation on the level of trascription factor GATA-1. Proc Natl Acad Sci USA 1997; 94: 6781-5.
• 44 Vyas P, Ault K, Jackson CW. et al. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999; 93: 2867-75.
• 45 Chang AN, Cantor AB, Fujiwara Y. et al. GATA-factor dependence of the multiple zincfinger protein FOG-1 for its essential role in megakaryopoiesis. Proc Natl Acad Sci USA 2002; 99: 9237-42.